{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:48:58Z","timestamp":1792082938491,"version":"4.4.0"},"reference-count":89,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Inflammatory bowel diseases (IBD), including Crohn\u2019s disease (CD) and ulcerative colitis (UC), are a major healthcare challenge worldwide. Disturbances in the immune system and gut microbiota followed by environmental triggers are thought to be part of the aetiological factors. Current treatment for IBD includes corticosteroids, immunosuppressants, and other biologic agents; however, some patients are still unresponsive, and these are also linked to high financial load and severe side effects. Plant-derived natural products are rich in phytochemicals and have been used as healing agents in several diseases since antiquity due to their antioxidant, anti-inflammatory, and immunomodulatory properties, as well as gut microbiota modulation. Numerous in vitro and in vivo studies have shown that phytochemicals act in key pathways that are associated with the pathogenesis of IBD. It is also reported that the use of plant-derived natural products as complementary treatments is increasing amongst patients with IBD to avoid the side effects accompanying standard medical treatment. This review summarises the relevant evidence around the use of plant-derived natural products in the management of IBD, with specific focus on the clinical evidence so far for Curcumin, Mastiha, Boswellia serrata, and Artemisia absinthium.<\/jats:p>","DOI":"10.3390\/life13081703","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T12:35:42Z","timestamp":1691498142000},"page":"1703","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Role of Plant-Derived Natural Products in the Management of Inflammatory Bowel Disease\u2014What Is the Clinical Evidence So Far?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5175-2466","authenticated-orcid":false,"given":"Mariela Martinez","family":"Davila","sequence":"first","affiliation":[{"name":"Division of Medicine, University College London, London WC1E 6JF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2406-4602","authenticated-orcid":false,"given":"Efstathia","family":"Papada","sequence":"additional","affiliation":[{"name":"Division of Medicine, University College London, London WC1E 6JF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: Clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3748\/wjg.v22.i3.1045","article-title":"Advances in nutritional therapy in inflammatory bowel diseases: Review","volume":"22","author":"Tomasik","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kayal, M., and Shah, S. (2019). Ulcerative Colitis: Current and Emerging Treatment Strategies. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010094"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jgh.14872","article-title":"The epidemiology of inflammatory bowel disease: East meets west","volume":"35","author":"Mak","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fcell.2015.00062","article-title":"Mitochondrial dysfunction in inflammatory bowel disease","volume":"3","author":"Novak","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"715506","DOI":"10.3389\/fphys.2021.715506","article-title":"Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease","volume":"12","author":"Sultan","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4240\/wjgs.v8.i5.363","article-title":"Inflammatory bowel disease surgery in the biologic era","volume":"8","author":"Ferrari","year":"2016","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"De Conno, B., Pesce, M., Chiurazzi, M., Andreozzi, M., Rurgo, S., Corpetti, C., Seguella, L., Del Re, A., Palenca, I., and Esposito, G. (2022). Nutraceuticals and Diet Supplements in Crohn\u2019s Disease: A General Overview of the Most Promising Approaches in the Clinic. Foods, 11.","DOI":"10.3390\/foods11071044"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21138","DOI":"10.3390\/molecules201219753","article-title":"Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases","volume":"20","author":"Zhang","year":"2015","journal-title":"Molecules"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Prakash, B. (2020). Functional and Preservative Properties of Phytochemicals, Academic Press.","DOI":"10.1016\/B978-0-12-818593-3.00001-4"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tiwari, B.K., Brunton, N.P., and Brennan, C. (2013). Handbook of Plant Food Phytochemicals: Sources, Stability and Extraction, Wiley-Blackwell.","DOI":"10.1002\/9781118464717"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3748\/wjg.v23.i14.2483","article-title":"Potential role of nutraceutical compounds in inflammatory bowel disease","volume":"23","author":"Larussa","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9346470","DOI":"10.1155\/2016\/9346470","article-title":"Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls","volume":"2016","author":"Kaulmann","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/10408398.2019.1570913","article-title":"Phytochemicals and inflammatory bowel disease: A review","volume":"60","author":"Hossen","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Holleran, G., Lopetuso, L., Petito, V., Graziani, C., Ianiro, G., Mcnamara, D., Gasbarrini, A., and Scaldaferri, F. (2017). The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102020"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2019.12.004","article-title":"Curcumin ameliorates oxidative stress-induced intestinal barrier injury and mitochondrial damage by promoting Parkin dependent mitophagy through AMPK-TFEB signal pathway","volume":"147","author":"Cao","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3831\/KPI.2018.21.033","article-title":"Immunomodulatory and anti-inflammatory phytochemicals for the treatment of inflammatory bowel disease (IBD)","volume":"21","author":"Sodagari","year":"2018","journal-title":"J. Pharmacopunct."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1157023","DOI":"10.1155\/2021\/1157023","article-title":"Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility","volume":"2021","author":"Sameer","year":"2021","journal-title":"BioMed. Res. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.4049\/jimmunol.173.5.2913","article-title":"Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway but Not Toll\/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-\u03b2 (TRIF)-Dependent Pathway in TLR Signaling","volume":"173","author":"Gohda","year":"2004","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105753","DOI":"10.1016\/j.phrs.2021.105753","article-title":"Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action","volume":"171","author":"Amerikanou","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"k2179","DOI":"10.1136\/bmj.k2179","article-title":"Role of the gut microbiota in nutrition and health","volume":"361","author":"Valdes","year":"2018","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ajgsup.2012.4","article-title":"Intestinal microbes in inflammatory bowel diseases","volume":"1","author":"Sartor","year":"2012","journal-title":"Am. J. Gastroenterol. Suppl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2003.09.022","article-title":"Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products","volume":"36","author":"Rechner","year":"2004","journal-title":"Free Rad. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Santhiravel, S., Bekhit, A.E.-D.A., Mendis, E., Jacobs, J.L., Dunshea, F.R., Rajapakse, N., and Ponnampalam, E.N. (2022). The Impact of Plant Phytochemicals on the Gut Microbiota of Humans for a Balanced Life. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158124"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/DMSO.S192228","article-title":"Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice","volume":"12","author":"Campbell","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/jf803638d","article-title":"Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model","volume":"57","author":"Larrosa","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"726878","DOI":"10.3389\/fmicb.2021.726878","article-title":"Resveratrol Improves Growth Performance, Intestinal Morphology, and Microbiota Composition and Metabolism in Mice","volume":"12","author":"Zhuang","year":"2021","journal-title":"Front Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40168-021-01115-9","article-title":"Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis","volume":"9","author":"Wu","year":"2021","journal-title":"Microbiome"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","article-title":"Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease","volume":"158","author":"Palm","year":"2014","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1535370218763760","article-title":"Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis","volume":"243","author":"Lyu","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"12693","DOI":"10.1038\/srep12693","article-title":"Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome","volume":"5","author":"Pozuelo","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/09637486.2014.880670","article-title":"Interactions between prebiotics, probiotics, polyunsaturated fatty acids and polyphenols: Diet or supplementation for metabolic syndrome prevention?","volume":"65","author":"Peluso","year":"2014","journal-title":"Int. J. Food. Sci. Nutr."},{"key":"ref_34","first-page":"415","article-title":"The use of complementary and alternative medicine in patients with Inflammatory Bowel Disease","volume":"14","author":"Lin","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Burge, K., Gunasekaran, A., Eckert, J., and Chaaban, H. (2019). Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081912"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjp.0705241","article-title":"Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis","volume":"139","author":"Ukil","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3748\/wjg.v11.i12.1747","article-title":"Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid","volume":"11","author":"Jian","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_38","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 969516, Curcumin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Curcumin."},{"key":"ref_39","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 6654, alpha-PINENE, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/alpha-PINENE."},{"key":"ref_40","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 14896, beta-Pinene, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/beta-Pinene."},{"key":"ref_41","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 31253, Myrcene, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Myrcene."},{"key":"ref_42","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 5951616, Masticadienonic acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Masticadienonic-acid."},{"key":"ref_43","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 15559978, Isomasticadienonic acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Isomasticadienonic-acid."},{"key":"ref_44","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 168928, beta-Boswellic acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/beta-Boswellic-acid."},{"key":"ref_45","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 261491, Thujone, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Thujone."},{"key":"ref_46","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 6616, Camphene, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Camphene."},{"key":"ref_47","unstructured":"National Center for Biotechnology Information (2023, July 31). PubChem Compound Summary for CID 442138, Absinthin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Absinthin."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic. Acids. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s10620-005-3032-8","article-title":"Curcumin therapy in inflammatory bowel disease: A pilot study","volume":"50","author":"Holt","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cgh.2006.08.008","article-title":"Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial","volume":"4","author":"Hanai","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MPG.0b013e318276977d","article-title":"Tolerability of curcumin in pediatric inflammatory bowel disease: A forced-dose titration study","volume":"56","author":"Suskind","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.crohns.2013.08.006","article-title":"Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis\u2014A randomized, placebo-controlled, pilot study","volume":"8","author":"Singla","year":"2014","journal-title":"J. Crohns. Colitis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","article-title":"Curcumin in Combination with Mesalamine Induces Remission in Patients with Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial","volume":"13","author":"Lang","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/ptr.6581","article-title":"The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis","volume":"34","author":"Sadeghi","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/advances\/nmx011","article-title":"The problem of Curcumin and its bioavailability: Could its gastrointestinal influence contribute to its overall health-enhancing effects?","volume":"9","author":"Lopresti","year":"2018","journal-title":"Adv. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1002\/jcb.27273","article-title":"The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients\u2019 self-reported well-being: A randomized double-blind controlled trial","volume":"119","author":"Masoodi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/ecco-jcc\/jjaa097","article-title":"Highly Bioavailable Curcumin Derivative Ameliorates Crohn\u2019s Disease Symptoms: A Randomized, Double-Blind, Multicenter Study","volume":"14","author":"Sugimoto","year":"2020","journal-title":"J. Crohns. Colitis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/MCG.0000000000001416","article-title":"Novel Bioenhanced Curcumin with Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study","volume":"55","author":"Banerjee","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4292\/wjgpt.v8.i2.147","article-title":"Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial","volume":"8","author":"Kedia","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.cgh.2019.08.041","article-title":"Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn\u2019s Disease After Surgery in a Randomized Controlled Trial","volume":"18","author":"Bommelaer","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Papada, E., and Kaliora, A.C. (2019). Antioxidant and Anti-Inflammatory Properties of Mastiha: A Review of Preclinical and Clinical Studies. Antioxidants, 8.","DOI":"10.3390\/antiox8070208"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Soulaidopoulos, S., Tsiogka, A., Chrysohoou, C., Lazarou, E., Aznaouridis, K., Doundoulakis, I., Tyrovola, D., Tousoulis, D., Tsioufis, K., and Vlachopoulos, C. (2022). Overview of Chios Mastic Gum (Pistacia lentiscus) Effects on Human Health. Nutrients, 14.","DOI":"10.3390\/nu14030590"},{"key":"ref_63","unstructured":"(2023, July 01). European Medicines Agency. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Herbal__Herbal_monograph\/2015\/07\/WC500190099.pdf."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3748\/wjg.v13.i5.748","article-title":"Chios mastic treatment of patients with active Crohn\u2019s disease","volume":"13","author":"Kaliora","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_65","first-page":"6031","article-title":"Alterations in the function of circulating mononuclear cells derived from patients with Crohn\u2019s disease treated with mastic","volume":"13","author":"Kaliora","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Papada, E., Forbes, A., Amerikanou, C., Torovi\u0107, L., Kalogeropoulos, N., Tzavara, C., Triantafillidis, J.K., and Kaliora, A.C. (2018). Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. Nutrients, 10.","DOI":"10.3390\/nu10111779"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ptr.6229","article-title":"Regulation of faecal biomarkers in inflammatory bowel disease patients treated with oral mastiha (Pistacia lentiscus) supplement: A double-blind and placebo-controlled randomised trial","volume":"33","author":"Papada","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/jcp.25407","article-title":"SHP-2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host-Microbiota Homeostasis","volume":"231","author":"Coulombe","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phymed.2018.08.008","article-title":"Plasma free amino acid profile in quiescent Inflammatory Bowel Disease patients orally administered with Mastiha (Pistacia lentiscus); a randomised clinical trial","volume":"56","author":"Papada","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"111535","DOI":"10.1016\/j.biopha.2021.111535","article-title":"Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with Mastiha","volume":"138","author":"Amerikanou","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_71","unstructured":"Gopi, S., Amalraj, A., Kunnumakkara, A., and Thomas, S. (2021). Inflammation and Natural Products, Academic Press."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2001-10708","article-title":"Therapy of active Crohn disease with Boswellia serrata extract H 15","volume":"39","author":"Gerhardt","year":"2001","journal-title":"Z. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ibd.21345","article-title":"Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn\u2019s disease: Good safety profile but lack of efficacy","volume":"17","author":"Holtmeier","year":"2011","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_74","first-page":"2695","article-title":"Managing ulcerative colitis in remission phase: Usefulness of Casperome\u00ae, an innovative lecithin-based delivery system of Boswellia serrata extract","volume":"20","author":"Pellegrini","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Szopa, A., Pajor, J., Klin, P., Rzepiela, A., Elansary, H.O., Al-Mana, F.A., Mattar, M.A., and Ekiert, H. (2020). Artemisia absinthium L.-Importance in the History of Medicine, the Latest Advances in Phytochemistry and Therapeutical, Cosmetological and Culinary Uses. Plants, 9.","DOI":"10.3390\/plants9091063"},{"key":"ref_76","first-page":"4850","article-title":"DA-9601, a standardized extract of Artemisia asiatica, blocks TNF-alpha-induced IL-8 and CCL20 production by inhibiting p38 kinase and NF-kappaB pathways in human gastric epithelial cells","volume":"12","author":"Choi","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.bjp.0706856","article-title":"The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes\/macrophages","volume":"149","author":"Hatziieremia","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phymed.2007.01.001","article-title":"Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn\u2019s disease: A double-blind placebo-controlled study","volume":"14","author":"Omer","year":"2007","journal-title":"Phytomedicine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.phymed.2009.10.013","article-title":"Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn\u2019s disease\u2014A controlled clinical trial","volume":"17","author":"Krebs","year":"2010","journal-title":"Phytomedicine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s11095-013-1193-2","article-title":"The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal data","volume":"31","author":"Hatley","year":"2014","journal-title":"Pharm. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: Food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.hermed.2015.03.001","article-title":"Curcumin, a golden spice with a low bioavailability","volume":"5","author":"Siviero","year":"2015","journal-title":"J. Herb. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2221-1691(13)60060-X","article-title":"Bioavailability enhancers of herbal origin: An overview","volume":"3","author":"Kesarwani","year":"2013","journal-title":"Asian Pac. J. Trop Biomed."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Tiwari, B.K., Brunton, N.P., and Brennan, C. (2013). Handbook of Plant Food Phytochemicals: Sources, Stability and Extraction, Wiley-Blackwell.","DOI":"10.1002\/9781118464717"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00394-015-1071-2","article-title":"Gender differences in plasma and urine metabolites from Sprague-Dawley rats after oral administration of normal and high doses of hydroxytyrosol, hydroxytyrosol acetate, and DOPAC","volume":"56","author":"Ferreres","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00394-013-0604-9","article-title":"Bioavailability of phenolics from an oleuropein-rich olive (Olea europaea) leaf extract and its acute effect on plasma antioxidant status: Comparison between pre- and postmenopausal women","volume":"53","author":"Larrosa","year":"2014","journal-title":"Eur. J. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1700751","DOI":"10.1002\/mnfr.201700751","article-title":"Bioavailability of Terpenes and Postprandial Effect on Human Antioxidant Potential. An Open-Label Study in Healthy Subjects","volume":"62","author":"Papada","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2022.09.026","article-title":"Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]","volume":"136","author":"Navarro","year":"2023","journal-title":"Am. J. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/8\/1703\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:27:50Z","timestamp":1760128070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/8\/1703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":89,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["life13081703"],"URL":"https:\/\/doi.org\/10.3390\/life13081703","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}